{
}
Pharmacy leaders highlight 2024 as a transformative year, emphasizing the growing focus on reimbursement practices and the role of pharmacy benefit managers (PBMs) in medication costs. The demand for GLP-1 obesity treatments is rising, potentially reshaping chronic disease management and healthcare costs in the U.S. Additionally, the Inflation Reduction Act may influence drug pricing and patient access, warranting close observation.
Jeffrey Keefer
People
The information provided herein is generated by experimental artificial intelligence and is for informational purposes only.
Pharma Leaders Discuss Key Trends Shaping Healthcare in 2024
21:03 05.12.2024
Trending
Subcategory
Stock Market Updates
Corporate News
Industry Trends
Finance Mergers & Acquisitions
Financial Scams and Security
Global Financial Events
Market Analysis and Predictions
Banking Regulations
Retail and Consumer Goods
Hedge Funds & Private Equity
Supply Chain Management
Global Trade Developments
Workplace Trends
Startups & Entrepreneurship
CEO Changes
AI Innovations
Real Estate Investments
Funding Rounds & Investments
Government Economic Policies
Cryptocurrency Trends
Countries:
Companies:
JPMorgan Chase & Co.
Barclays PLC
NVIDIA Corporation
Morgan Stanley
The Goldman Sachs Group, Inc.
Bank of America Corporation
Citigroup Inc.
Wells Fargo & Company
Tesla, Inc.
Apple Inc.
The Charles Schwab Corporation
Tesmec S.p.A.
Geode Capital Management LLC
State Street Corporation
Huawei Technologies CO. Ltd.
Netflix, Inc.
HSBC Holdings plc
Credit Suisse Real Estate Fund Siat
Charles Schwab Investment Management Inc.
UBS Group AG
Currencies:
United States Dollar
Chinese Yuan
Indian Rupee
British Pound Sterling
Swiss Franc
Euro
United Arab Emirates Dirham
South Korean Won
Canadian Dollar
Offshore Chinese Yuan
Japanese Yen
Azerbaijani Manat
New Taiwan Dollar
Saudi Riyal
Singapore Dollar
Vietnamese Đồng
Hong Kong Dollar
People: